Christina Sternberg

Dr. Christina Sternberg is a researcher at the Medical University of Vienna, affiliated with the Clinical Institute of Pathology. Her work focuses on prostate cancer mechanisms, particularly the role of IL6ST-mediated signaling and STAT3 activation in tumor suppression through cellular senescence and immune modulation. She holds a position in the Department of Pathology and has contributed to groundbreaking studies linking IL6ST activation to improved patient outcomes via immune-hot tumor microenvironments.

Research Highlights:

• Discovered tumor-suppressive role of IL6ST/STAT3 signaling in prostate cancer
• Showed IL6ST activation induces senescence via STAT3/ARF/p53 pathway
• Demonstrated enhanced cytotoxic T-cell recruitment in mouse models
• Linked high IL6ST mRNA levels to better recurrence-free survival in patients

Her 2024 publication in Molecular Cancer establishes foundational insights for potential therapeutic approaches targeting IL6ST activation in prostate cancer.